BridgeBio Pharma, Inc. Q2 FY2021 Earnings Call

BridgeBio Pharma, Inc. (BBIO)

Earnings Call FY2021 Q2 Call date: 2021-08-13 Concluded

Quarter scorecard

Revenue

$54.02M

Net income

-$102.07M

License And Service $53.04M

Product $987,000

Buybacks (derived)

$5.31M